Personalized Medicine, By Therapeutic (Oncology, Neurology, Cardiology, Antiviral, Psychiatry), By Application (Companion Diagnostics, Health Informatics, Biomarker Identification, Clinical Research), By Technology : (Pharmacogenomics, Metabolomics, Pharmacoproteomics, Pharmacogenetics, Stem cell therapy, Pharmacodynamics, Point of care, Pharmacokinetics), By End-User (Hospitals, Molecular Diagnostic Laboratories and Testing Facilities, Academic Institutes, Clinical Care, and Research Laboratories, Contract Research Organizations, Bio and Health Informatics Companies) and By Region - Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026


 Request Customization  Sample Request  Ask for Discount
 MDHEZ1H6KBYA  |    Jan 28, 2020


Personalized medicine produced based on the individual patient requirement or for the specific group of people who has certain biomarkers. Personalized medicines are created to serve the requirement of an individual patient who is suffering from particular diseases. The personalized medicines are majorly used for cancer treatment and the patient suffering from genetic disorders. The personalized medicine is one of the approaches which helps to provide higher treatment effectiveness to treat the patients to prevent and predict the diseases. Globally the personalized medicine market is growing due to increasing investment for the development of personalized medicines. For instance, the European Union has invested EUR 1 billion to focus on the development of personalized medicines in 2015. The European Union also entered into a collaboration with Health Technology Assessment to understand the cost-benefit-efficiency of the personalized medicines



The report offers detailed coverage of Personalized Medicine market and industry trends to provide a comprehensive view of the market. The Personalized Medicine research report includes market estimation & forecasting, demand & supply analysis, price trends, company market share of the leading players in Personalized Medicine market. The report splits the market based on various segments. The Personalized Medicine market report also describes the main players and how they are strengthening their position in the market with the latest innovations, strategic acquisitions, partnership and collaboration. It also provides the financial analysis, SWOT analysis, company overview and portfolio analysis of the leading players in the Personalized Medicine market. 

  • Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Qiagen
  • AstraZeneca Plc.
  • Merck & Co. Inc.
  • Siemens Healthcare GmbH
  • Vertex Pharmaceuticals Incorporated
  • Becton
  • Dickinson

Personalized Medicine Segments

The Personalized Medicine market is segmented as below

Segmentation

Therapeutic

  • Oncology
  • Neurology
  • Cardiology
  • Antiviral
  • Psychiatry

Application

  • Companion Diagnostics
  • Health Informatics
  • Biomarker Identification
  • Clinical Research

Technology :

  • Pharmacogenomics
  • Metabolomics
  • Pharmacoproteomics
  • Pharmacogenetics
  • Stem cell therapy
  • Pharmacodynamics
  • Point of care
  • Pharmacokinetics

End-User

  • Hospitals
  • Molecular Diagnostic Laboratories and Testing Facilities
  • Academic Institutes
  • Clinical Care
  • and Research Laboratories
  • Contract Research Organizations
  • Bio and Health Informatics Companies

The Personalized Medicine market report brings market data at one point to understand the Personalized Medicine market growth trends, market size, and future scenario of the market. This analysis will help clients to plan their expansion, investment, merger acquisition strategy and bring the improvement. All the data of Personalized Medicine market is demonstrated in such a way that the end-user can leverage the analyzed data. The analysis includes all segment and sub-segment analysis and their scope, growth rate, market opportunities and challenges. 



The qualitative analysis of Personalized Medicine market report includes competitive landscape, key growth, and restraining factors. In addition to this, the PESTEL, Porter's Five, and Value chain analysis enables users to understand how the micro and macro-economic factors have influenced the Personalized Medicine market.  The global analysis of Personalized Medicine market report allows users to understand the competitive factors in the market, which help them to take strategic business decisions for sustainable growth. 

In Personalized Medicine market report the top-down and bottom-up approach has applied to estimate the market value. In the top-down and bottom-up approach, the report considered primary and secondary research. In the primary research, multiple interviews were conducted with CEOs, CFOs, and product managers of the leading players. The interviews also include the subject matter expert, investors, and end-user interviews. Secondary research includes company annual reports, press releases, whitepapers, market players’ association news portal, government portal, and journals. 

Market Density

Market Density is one-stop market research, advisory, consulting and, industry analysis reports platform. The reports' library providing business data and intelligence information on thousands of micro as well as high growth markets with global as well as regional coverage. Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for B2B, B2C, and government organizations around the globe. Market Density helps global clients to deal with the business challenges in the competitive world for sustainable growth.

Contact information:

4340 Stevens Creek Blvd,
Suite # 172.
San Jose, CA 95129
Ph : +1 669 264 1656
Email : sales@marketdensity.com

 

  • About Us
    • Why Should you buy this report (sample)
    • How this report delivers? (sample)
    • Key Questions Answered(sample)
  • Chapter 1: Introduction to Personalized Medicine Market
    • Market Definition
    • Market Segmentation
    • Macro Economic Factor Analysis
  • Chapter 2: Executive Summary
  • Chapter 3: Market Factor Analysis
    • Porter’s Five Forces Analysis
    • PESTEL Analysis
    • Value Chain Analysis
    • SWOT Analysis
    • Pricing Analysis
  • Chapter 4: Global Personalized Medicine Market Estimation & Forecast By Therapeutic
    • Oncology
    • Neurology
    • Cardiology
    • Antiviral
    • Psychiatry
  • Chapter 5: Global Personalized Medicine Market Estimation & Forecast By Application
    • Companion Diagnostics
    • Health Informatics
    • Biomarker Identification
    • Clinical Research
  • Chapter 6: Global Personalized Medicine Market Estimation & Forecast By Technology :
    • Pharmacogenomics
    • Metabolomics
    • Pharmacoproteomics
    • Pharmacogenetics
    • Stem cell therapy
    • Pharmacodynamics
    • Point of care
    • Pharmacokinetics
  • Chapter 7: Global Personalized Medicine Market Estimation & Forecast By End-User
    • Hospitals
    • Molecular Diagnostic Laboratories and Testing Facilities
    • Academic Institutes, Clinical Care, and Research Laboratories
    • Contract Research Organizations
    • Bio and Health Informatics Companies
  • Chapter 8 Global Personalized Medicine Market Estimation & Forecast By Region
    • North America
    • Asia Pacific
    • Europe
    • EMEA
    • Latin America
  • Chapter 9 Competitive Landscape
    • Competition Mapping
    • Company Profiles (Suppliers)
      • Hoffmann-La Roche Ltd.
      • Pfizer Inc.
      • Qiagen
      • AstraZeneca Plc.
      • Merck & Co. Inc.
      • Siemens Healthcare GmbH
      • Vertex Pharmaceuticals Incorporated
      • Becton
      • Dickinson
  • Chapter 10 Recommendations
  • Chapter 11 Acronyms and Assumptions

Purchase options

Single User $ 2100.00
Corporate User $ 3000.00